DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma

Abstract Germline single nucleotide polymorphisms in the promoter region of the DCBLD1 gene are associated with non-smoking cases of both non-small cell lung carcinoma (NSCLC) and human papillomavirus-negative head and neck cancer. However the clinical relevance and function of DCBLD1 remain unclear...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Guillaume B. Cardin, Monique Bernard, Francis Rodier, Apostolos Christopoulos
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8ba00709e590431b8952cc5729226de6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8ba00709e590431b8952cc5729226de6
record_format dspace
spelling oai:doaj.org-article:8ba00709e590431b8952cc5729226de62021-12-02T16:04:23ZDCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma10.1038/s41598-021-92090-62045-2322https://doaj.org/article/8ba00709e590431b8952cc5729226de62021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-92090-6https://doaj.org/toc/2045-2322Abstract Germline single nucleotide polymorphisms in the promoter region of the DCBLD1 gene are associated with non-smoking cases of both non-small cell lung carcinoma (NSCLC) and human papillomavirus-negative head and neck cancer. However the clinical relevance and function of DCBLD1 remain unclear. This multicenter retrospective study was designed to evaluate the prognostic value and function of DCBLD1 in the four main solid cancers: NSCLC, invasive breast carcinoma, colorectal adenocarcinoma and prostate adenocarcinoma. We included the following cohorts: GSE81089 NSCLC, METABRIC invasive breast carcinoma, GSE14333 colorectal adenocarcinoma, GSE70770 prostate adenocarcinoma and The Cancer Genome Atlas (TCGA) Firehose Legacy cohorts of all four cancers. DCBLD1 gene expression was associated with a worse overall survival in multivariate analyses for both NSCLC cohorts (TCGA: P = 0.03 and GSE81089: P = 0.04) and both invasive breast carcinoma cohorts (TCGA: P = 0.02 and METABRIC: P < 0.001). Patients with high DCBLD1 expression showed an upregulation of the integrin signaling pathway in comparison to those with low DCBLD1 expression in the TCGA NSCLC cohort (FDR = 5.16 × 10–14) and TCGA invasive breast carcinoma cohort (FDR = 1.94 × 10–05).Guillaume B. CardinMonique BernardFrancis RodierApostolos ChristopoulosNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Guillaume B. Cardin
Monique Bernard
Francis Rodier
Apostolos Christopoulos
DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma
description Abstract Germline single nucleotide polymorphisms in the promoter region of the DCBLD1 gene are associated with non-smoking cases of both non-small cell lung carcinoma (NSCLC) and human papillomavirus-negative head and neck cancer. However the clinical relevance and function of DCBLD1 remain unclear. This multicenter retrospective study was designed to evaluate the prognostic value and function of DCBLD1 in the four main solid cancers: NSCLC, invasive breast carcinoma, colorectal adenocarcinoma and prostate adenocarcinoma. We included the following cohorts: GSE81089 NSCLC, METABRIC invasive breast carcinoma, GSE14333 colorectal adenocarcinoma, GSE70770 prostate adenocarcinoma and The Cancer Genome Atlas (TCGA) Firehose Legacy cohorts of all four cancers. DCBLD1 gene expression was associated with a worse overall survival in multivariate analyses for both NSCLC cohorts (TCGA: P = 0.03 and GSE81089: P = 0.04) and both invasive breast carcinoma cohorts (TCGA: P = 0.02 and METABRIC: P < 0.001). Patients with high DCBLD1 expression showed an upregulation of the integrin signaling pathway in comparison to those with low DCBLD1 expression in the TCGA NSCLC cohort (FDR = 5.16 × 10–14) and TCGA invasive breast carcinoma cohort (FDR = 1.94 × 10–05).
format article
author Guillaume B. Cardin
Monique Bernard
Francis Rodier
Apostolos Christopoulos
author_facet Guillaume B. Cardin
Monique Bernard
Francis Rodier
Apostolos Christopoulos
author_sort Guillaume B. Cardin
title DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma
title_short DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma
title_full DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma
title_fullStr DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma
title_full_unstemmed DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma
title_sort dcbld1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/8ba00709e590431b8952cc5729226de6
work_keys_str_mv AT guillaumebcardin dcbld1isassociatedwiththeintegrinsignalingpathwayandhasprognosticvalueinnonsmallcelllungandinvasivebreastcarcinoma
AT moniquebernard dcbld1isassociatedwiththeintegrinsignalingpathwayandhasprognosticvalueinnonsmallcelllungandinvasivebreastcarcinoma
AT francisrodier dcbld1isassociatedwiththeintegrinsignalingpathwayandhasprognosticvalueinnonsmallcelllungandinvasivebreastcarcinoma
AT apostoloschristopoulos dcbld1isassociatedwiththeintegrinsignalingpathwayandhasprognosticvalueinnonsmallcelllungandinvasivebreastcarcinoma
_version_ 1718385218764668928